AUD 0.13
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Operating Cash Flow | -779.6 Thousand | -855.45 Thousand | -961.87 Thousand | -394.2 Thousand |
Net Income | -797.64 Thousand | -752.72 Thousand | -1.52 Million | -522.2 Thousand |
Depreciation & Amortization | 9393.00 | 60 Thousand | 226.82 Thousand | - |
Deferred income taxes | - | -246.72 Thousand | -83.49 Thousand | - |
Stock-based compensation | 50.38 Thousand | 55.68 Thousand | 92.3 Thousand | - |
Change in working capital | 7490.00 | -102.91 Thousand | 239.72 Thousand | 128 Thousand |
Other non-cash items | -49.22 Thousand | 131.22 Thousand | 83.49 Thousand | -127.02 Thousand |
Investing Cash Flow | -1.09 Million | -1.48 Million | - | -246.82 Thousand |
Investments in PPE | -1.09 Million | -1.48 Million | - | -226.82 Thousand |
Acquisitions | - | - | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | -1.48 Million | - | -20 Thousand |
Financing Cash Flow | - | 5.57 Million | 1.05 Million | 665.4 Thousand |
Debt repayment | - | - | - | -100 Thousand |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | -422.58 Thousand | - | - |
Common Stock Issuance | - | 5.57 Million | 1.05 Million | 565.4 Thousand |
Other Financing Activities | - | 422.58 Thousand | 1.05 Million | - |
Accounts receivables | 9787.00 | -24.15 Thousand | 6902.00 | -10.07 Thousand |
Accounts payables | - | -106.88 Thousand | 228.73 Thousand | 137.1 Thousand |
Inventory | - | - | - | - |
Other working capital | -2297.00 | 28.12 Thousand | 4083.00 | 976.00 |
Cash at beginning of period | 3.35 Million | 113.77 Thousand | 24.37 Thousand | - |
Cash at end of period | 1.48 Million | 3.35 Million | 113.77 Thousand | 24.37 Thousand |
Capital Expenditure | -1.09 Million | -1.48 Million | - | -226.82 Thousand |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | -1.87 Million | 3.24 Million | 89.4 Thousand | 24.37 Thousand |
Free Cash Flow | -1.87 Million | -2.33 Million | -961.87 Thousand | -621.02 Thousand |
Breakdown | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -267.38 Thousand | -530.25 Thousand | -752.72 Thousand | -343.53 Thousand | -409.19 Thousand | -451.74 Thousand |
Depreciation & Amortization | -46.99 Thousand | 56.38 Thousand | 60 Thousand | 60 Thousand | - | -385.38 Thousand |
Deferred income taxes | - | - | -246.72 Thousand | -74.35 Thousand | - | 595.53 Thousand |
Stock-based compensation | 25.05 Thousand | 25.32 Thousand | 55.68 Thousand | 38.51 Thousand | 17.16 Thousand | 26.3 Thousand |
Change in working capital | 7490.00 | - | -102.91 Thousand | 3969.00 | - | 240.23 Thousand |
Other non-cash items | -11.19 Thousand | -38.02 Thousand | 131.22 Thousand | 64.24 Thousand | -166.97 Thousand | -225.1 Thousand |
Investing Cash Flow | -336.07 Thousand | -758.6 Thousand | -1.48 Million | -542.78 Thousand | -937.45 Thousand | - |
Investments in PPE | -336.07 Thousand | -758.6 Thousand | -1.48 Million | -542.78 Thousand | -937.45 Thousand | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -200 Thousand | - | - | - | - |
Financing Cash Flow | - | - | 5.57 Million | - | 5.57 Million | 282 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -422.58 Thousand | - | - | - |
Common Stock Issuance | - | - | 5.57 Million | - | 5.57 Million | 282 Thousand |
Other Financing Activities | - | - | 422.58 Thousand | - | 5.57 Million | 282 Thousand |
Accounts receivables | 9787.00 | - | -24.15 Thousand | -24.15 Thousand | - | 99.2 Thousand |
Accounts payables | - | - | -106.88 Thousand | - | - | 137.25 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -2297.00 | - | 28.12 Thousand | 28.12 Thousand | - | 3772.00 |
Cash at beginning of period | 2.11 Million | 3.35 Million | 113.77 Thousand | 4.17 Million | 113.77 Thousand | 31.93 Thousand |
Cash at end of period | 1.48 Million | 2.11 Million | 3.35 Million | 3.35 Million | 4.17 Million | 113.77 Thousand |
Capital Expenditure | -336.07 Thousand | -758.6 Thousand | -1.48 Million | -542.78 Thousand | -937.45 Thousand | - |
Effect of forex changes on cash | - | - | - | - | 113.77 Thousand | - |
Net cash flow / Change in cash | -629.11 Thousand | -1.24 Million | 3.24 Million | -822.07 Thousand | 4.06 Million | 81.84 Thousand |
Free Cash Flow | -629.11 Thousand | -1.24 Million | -2.33 Million | -822.07 Thousand | -1.51 Million | -200.15 Thousand |
LODHA
CME
AMBUJACEM
6272
9744
PFIZER